Dec 28, 2023

Featuring perspectives from Prof Francois-Clement Bidard, Dr Erika Hamilton, Dr Komal Jhaveri, Dr Virginia Kaklamani and Dr Hope S Rugo, including the following topics:

• Introduction (0:00)
• Role of Genomic Assays in Treatment Decision-Making for Localized ER-Positive, HER2-Negative Breast Cancer — Dr Goetz (6:03)

Dec 27, 2023

Featuring perspectives from Dr Jeremy S Abramson, Dr Stephen M Ansell, Dr Nancy L Bartlett, Dr Jonathon B Cohen, Dr Jonathan W Friedberg and Dr Brad S Kahl, including the following topics:

• Introduction (0:00)
• Evolving Role of Novel Treatment Strategies in Follicular Lymphoma (FL) — Dr Friedberg (7:20)
• Integration...

Dec 21, 2023

Featuring perspectives from Prof Francois-Clement Bidard, Dr Erika Hamilton, Dr Komal Jhaveri, Dr Virginia Kaklamani and Dr Hope S Rugo, including the following topics:

• Introduction (0:00)
• Optimal Integration of CDK4/6 Inhibitors into the Management of ER-Positive Metastatic Breast Cancer (mBC) — Dr Kaklamani...

Dec 20, 2023

Featuring an interview with Dr David M O’Malley, including the following topics:

• Prevalence of HER2 positivity among various gynecologic cancer subtypes; current testing recommendations (0:00)
• Trastuzumab and other HER2-targeted therapies as a component of treatment for HER2-positive gynecologic cancers (15:17)
• Key...

Dec 14, 2023

Featuring perspectives from Dr Lipika Goyal and Dr Milind Javle, including the following topics:

• Introduction (0:00)
• First-Line Systemic Treatment (17:25)
• Targeted Treatment (25:42)

CME information and select publications